Farias DLC, Prats J, Cavalcanti AB, Rosa RG, Machado FR et al. Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS). Rev Bras Ter Intensiva. 2020 Jul-Sep;32(3):337-347.